EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 3.0

Efficacy and Safety of Clobazam Adjunctive Therapy in Pediatric Patients with Drug-Resistant Epilepsy

Lingyan Yu iD, Shunan Chen, Zhou Zhang iD, Yani Hu, Yuting Fang, Fengqian Mao, Suhong Wang, Zhenwei Yu iD, Xuejuan Li iD, Haibin Dai iD

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s560731 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Lingyan Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, People's Republic of China. Hauptthemen laut MEDLINE: Clobazam, Drug Resistant Epilepsy, Anticonvulsants, Benzodiazepines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClobazamDrug Resistant EpilepsyAnticonvulsantsBenzodiazepinesHumansChildMaleFemaleRetrospective StudiesAdolescentChild, PreschoolTreatment OutcomeDrug Therapy, Combination

Stichwörter der Autor:innen

adjunctive therapyclobazamdrug-resistant epilepsypediatric patient

Substanzen

ClobazamAnticonvulsantsBenzodiazepines

Autor:innen und Institutionen

  • Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, People's Republic of China.
  • Research Center for Clinical Pharmacy, Zhejiang University, Hangzhou, 310058, People's Republic of China.
  • School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, People's Republic of China.
  • Shenzhen Children's Hospital, Shenzhen, 518026, People's Republic of China.
  • First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), Hefei, 230001, People's Republic of China.
  • Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, People's Republic of China.

ORCID-Profile: Lingyan Yu, Zhou Zhang, Zhenwei Yu, Xuejuan Li, Haibin Dai

Zitieren

APA

Yu, L., Chen, S., Zhang, Z., Hu, Y., Fang, Y., Mao, F., Wang, S., Yu, Z., Li, X., & Dai, H. (2025). Efficacy and Safety of Clobazam Adjunctive Therapy in Pediatric Patients with Drug-Resistant Epilepsy. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s560731

Vancouver

Yu L, Chen S, Zhang Z, Hu Y, Fang Y, Mao F, et al. Efficacy and Safety of Clobazam Adjunctive Therapy in Pediatric Patients with Drug-Resistant Epilepsy. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s560731

BibTeX
@article{Yu2025,
  author = {Yu, Lingyan and Chen, Shunan and Zhang, Zhou and Hu, Yani and Fang, Yuting and Mao, Fengqian and Wang, Suhong and Yu, Zhenwei and Li, Xuejuan and Dai, Haibin},
  title = {Efficacy and Safety of Clobazam Adjunctive Therapy in Pediatric Patients with Drug-Resistant Epilepsy},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s560731}
}
Kostenlos starten →